Results

Total Results: 2,279 records

Showing results for "factor".

21. Transparency of Reporting Requirements Project: Management of Infertility | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/transparency-infertility/research-protocol
    January 01, 2019 - subfertile/infertile women by etiology (e.g., endometriosis), one addressing treatment strategies for male factor … for different etiologies (i.e., KQ 1, polycystic ovarian syndrome; KQ 2, endometriosis; KQ 4, tubal factor … body mass index (BMI), presence of other potential causes of female infertility, or presence of male factor … stage of endometriosis, presence of other potential causes of female infertility, or presence of male factor … are the comparative safety and effectiveness of available treatment strategies for couples with male factor

22. MEDLINE Searches (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/breast-cancer-medications_appendixes.pdf
    March 01, 2009 - Single risk factor only 102. Dignam JJ, Fisher B. … Effect of raloxifene on insulin-like growth factor-I, insulin-like growth factor binding protein-3, … Single risk factor only 230. Potter CE, Beldock JG. … Single risk factor only 237. Rhodes DJ. … Single risk factor only 273. Swerdlow AJ, Jones ME.

23. Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/maternal-morbidity-mortality/research
    May 01, 2024 - Limited depth and quality of available research within each risk factor domain—including racism and other … intersecting social-structural determinants of health that is an exemplar of new approaches to risk factor … and structural determinant of health impeded our ability to outline specific pathways, including risk factor

24. Management of Infertility | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/infertility/research-protocol
    October 01, 2019 - Treatment options for male factor infertility include medical treatment of a diagnosed endocrinopathy … or peritoneal factor (e.g., pelvic adhesions) infertility who are subfertile/infertile and who wish … Temporal and geospatial trends in male factor infertility with assisted reproductive technology in the … Tubal factor infertility and perinatal risk after assisted reproductive technology. … or peritoneal factor (e.g., pelvic adhesions) infertility who are subfertile/infertile and who wish

25. Executive summary_Comparative Effectiveness Review No. 264_Social and Structural Determinants of Maternal Morbidity and Mortality: An Evidence Map (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-264-maternal-morbidity-mortality-executive-summary.pdf
    December 01, 2023 - • Limited depth and quality of available research within each risk factor domain— including racism … intersecting social-structural determinants of health that is an exemplar of new approaches to risk factor … intersecting social-structural determinants of health that is an exemplar of new approaches to risk factor … Limited depth and quality of available research within each risk factor impeded our ability to outline

26. Transparency of Reporting Requirements: Management of Infertility (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/transparency-infertility_research-protocol.pdf
    September 02, 2016 - for different etiologies (i.e., KQ 1, polycystic ovarian syndrome; KQ 2, endometriosis; KQ 4, tubal factor … body mass index (BMI), presence of other potential causes of female infertility, or presence of male factor … reserve, race, BMI, presence of other potential causes of female infertility, or presence of male factor … reserve, race, BMI, presence of other potential causes of female infertility, or presence of male factor … : o ICSI (note that interventions and comparators may vary depending on underlying cause of male factor

27. Comparative Effectiveness of Pharmacologic and Mechanical Prophylaxis of Venous Thromboembolism Among Special Populations | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/vte-prophyalaxis/research-protocol
    December 01, 2019 - Because of their decreased binding to platelet factor 4, LMWHs have a lower incidence of thrombocytopenia … Rivaroxaban is an oral factor Xa inhibitor that was approved by the FDA in July 2011 for VTE prophylaxis … Trauma is known to be a major risk factor for VTE. … Xa inhibitors, direct thrombin inhibitors) Pharmacologic (UFH, LMWHs, factor Xa inhibitors … We will consider low-dose UFH, LMWHs, factor Xa inhibitors, direct thrombin inhibitors, and mechanical

28. CER 217 Management of Infertility Evidence Summary (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-217-infertility-evidence-summary.pdf
    May 01, 2019 - The most common demographic factor associated with female infertility is “advanced reproductive age … 6 PCOS Endometriosis Unexplained Infertility Tubal or Peritoneal Factor KQ 1 KQ 2 KQ 3 KQ 4 … addressed outcomes after treatment for tubal or peritoneal factor infertility. … infertility (KQ 4); and male factor infertility (KQ 5). … Tubal factor infertility and perinatal risk after assisted reproductive technology.

29. Musculoskeletal-Complaints-Tests-Children Surveillance (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/musculoskeletal-complaints-tests-children_surveillance.pdf
    January 08, 2013 - CER #50: Antinuclear Antibody, Rheumatoid Factor, and Cyclic-Citrullinated Peptide Tests for Evaluating … .................................................... 5 1 Antinuclear Antibody, Rheumatoid Factor … Introduction Comparative Effectiveness Review (CER) #50, Antinuclear Antibody, Rheumatoid Factor … we had also identified in our electronic search.7 That study reported the prevalence of Rheumatoid Factor … / or (rheumatoid adj factor*).ti,ab. 4 limit 3 to (english language and yr="2009 - 2013") 5 2 or

30. Treatment of Osteoarthritis of the Knee: An Update | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/osteoarthritis-knee-update/research-protocol
    July 01, 2021 - natural joint lubricant, hyaluronic acid (HA), experimental use of biologic agents (anti-nerve growth factor … antibodies or anti-tumor necrosis factor antibodies, which are used to treat rheumatoid arthritis), … Platelet Rich Plasma ACR: not mentioned AAOS: unable to recommend for or against growth factor … anakinra OR canakinumab OR "platelet rich plasma" OR "platelet-rich plasma" OR PRP OR "nerve growth factor … '/exp OR 'nerve growth factor' OR (('fibroblast' OR 'fibroblast'/exp OR fibroblast) AND ('growth' OR

31. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/vte-prophyalaxis_research-protocol.pdf
    March 01, 2011 - Because of their decreased binding to platelet factor 4, LMWHs have a lower incidence of thrombocytopenia … Rivaroxaban is an oral factor Xa inhibitor that was approved by the FDA in July 2011 for VTE prophylaxis … Trauma is known to be a major risk factor for VTE. …  We will consider low-dose UFH, LMWHs, factor Xa inhibitors, direct thrombin inhibitors, and …  We will consider low-dose UFH, LMWHs, factor Xa inhibitors, direct thrombin inhibitors, and

32. Untitled (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/infertility_research-protocol.pdf
    October 12, 2015 - • Male)Factor KQ#5 KQ#6 ! … factor!infertility,!other!female!causes!of!infertility,!or! common!comorbidities!such!as! … factor!infertility,!presence!of! endometrioma,!other!female!causes!of!infertility,!or! common! … factor!infertility),!testicular!sperm!extraction,! vasectomy!reversal,!surgical!repair!of! … Tubal factor infertility and perinatal risk after assisted reproductive technology.

33. CER 217 Disposition of Comments: Management of Infertility (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/cer-217-management-of-infertility-comments.pdf
    May 14, 2019 - Some of these concepts I am trying to bring out (IE ICIS works for male factor infertility) can be … IE start with ICIS works for male factor in the introduction and then state looking at subgroups IE … (Page 12, line 24) We have clarified that this is the most common demographic factor, not the most … We agree that the evidence supporting male factor infertility treatments is sparse. … We agree that the evidence supporting male factor infertility treatments is sparse.

34. Evidence-based Practice Center Systematic Review Protocol (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/musculoskeletal-complaints-tests-children_research-protocol.pdf
    September 29, 2010 - Evidence-based Practice Center Systematic Review Protocol Project Title: Antinuclear Antibody, Rheumatoid Factor … or limb or joint swelling may use serological tests such as antinuclear antibody (ANA), rheumatoid factor … The rheumatoid factor (RF) test is the most commonly used serological test to determine the presence … Rheumatoid factor and anti-CCP autoantibodies in rheumatoid arthritis: A review. … • Rheumatoid factor test (RF): The measure of serum level of rheumatoid factor antibody which is

35. Effective Health Care (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/TND_0319_06-17-2009.pdf
    January 01, 2009 - fibrinogen, leukocyte count, prothrombin time, partial thrombin time, interleukin 6, and tumor necrosis factor … fibrinogen, leukocyte count, prothrombin time, partial thrombin time, interleukin 6, and tumor necrosis factor

36. Treatment of Osteoarthritis of the Knee: An Update (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/osteoarthritis-knee-update_research-protocol.pdf
    June 15, 2016 - natural joint lubricant, hyaluronic acid (HA), experimental use of biologic agents (anti-nerve growth factor … antibodies or anti-tumor necrosis factor antibodies, which are used to treat rheumatoid arthritis), … FDA- CMS National Coverage Determination: Plasma AAOS: unable to recommend for or against growth factor … '/exp OR 'nerve growth factor' OR (('fibroblast' OR 'fibroblast'/exp OR fibroblast) AND ('growth' OR … '/exp OR 'nerve growth factor' OR ('fibroblast' OR 'fibroblast'/exp OR fibroblast AND ('growth' OR '

37. S116 (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/s116.pdf
    October 01, 2007 - This factor will be a valid IV if: (1) physicians vary in their preference for using the 2 different … The reported prevalence difference (PD) is the prev- alence of the risk factor among patients started … on an atypical APM minus the prevalence of the risk factor among patients started on a conventional … The reported PD for the IV is the prevalence of the risk factor among patients of physicians who have … †Prevalence of risk factor among atypical users minus prevalence of risk factor among conventional users

38. Systematic Review Update of Venous Thromboembolism Prophylaxis in Orthopedic Surgery | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/products/thromboembolism-update/research-protocol
    January 01, 2021 - There were few studies evaluating the new factor Xa inhibitors. … efficacy of individual thromboprophylaxis interventions within classes (low molecular weight heparin, factor … or treatment durations of the same thromboprophylaxis interventions (low molecular weight heparin, factor … (All KQ) Injectable unfractionated heparin (KQ 1, 4 [in combination,] 5, 6) Injectable or oral factor … 1) comparisons of classes of thromboprophylaxis interventions (e.g., low molecular weight heparin, factor

39. Executive Summary_Systematic Review: Mental Health and Occupational Stress in the Emergency Medical Services and 911 Workforces (pdf file)
    effectivehealthcare-admin.ahrq.gov/sites/default/files/related_files/ems-911-workforce-mental-health-executive-summary.pdf
    February 01, 2025 - 1: Associations between modifying factors and all outcomes among telecommunicators Level Modifying Factor … Numbers in parentheses refer to numbers of studies that evaluated the modifying factor (row) for the … between modifying factors and all outcomes among Emergency Medical Services clinicians Level Modifying Factor … No psychological help . . ↑ (1) . . . . . . 11 Level Modifying Factor Depression … Numbers in parentheses refer to numbers of studies that evaluated the modifying factor (row) for the

40. Population: Children < 18 years of age: 1. What are the incidences and prevalences of non-inflammatory pain syndromes (e.g., benign hypermobility syndrome, patellofemoral stress syndrome, fibromyalgia, and growing pain) in children and… | Effective Health Care (EHC) Program
    effectivehealthcare-admin.ahrq.gov/get-involved/nominated-topics/population-children-18-years-of-age-1-what-are-the-incidences-and-prevalences-of-non-inflammatory-pain-syndromes-eg-benign-hypermobility-syndrome-patellofemoral-stress-syndrome-fibromyalgia-and-growing-pain-in-children-and-a
    November 01, 2017 - a) What is the diagnostic accuracy of antinuclear antibody (ANA) and rheumatoid factor (RF) for children … interventions you would like to see compared: What is the diagnositic accuracy of ANA and Rheumatoid factor … Disposition (PDF, 132.9 KB) Project Timeline Antinuclear Antibody, Rheumatoid Factor